- Home
- CTNM vs NMAI Comparison
CTNM vs NMAI Comparison
Compare CTNM & NMAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | CTNM | NMAI |
|---|---|---|
| Founded | 2009 | 2021 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Investment Managers |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 416.1M | 429.9M |
| IPO Year | 2024 | N/A |
Fundamental Metrics
Financial Performance| Metric | CTNM | NMAI |
|---|---|---|
| Price | $11.44 | $13.02 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $20.00 | N/A |
| AVG Volume (30 Days) | ★ 260.9K | 74.8K |
| Earning Date | 10-30-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 13.14% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.64 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $19.03 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.35 | $10.60 |
| 52 Week High | $15.25 | $12.55 |
Technical Indicators
Market Signals| Indicator | CTNM | NMAI |
|---|---|---|
| Relative Strength Index (RSI) | 46.77 | 50.32 |
| Support Level | $11.66 | $12.94 |
| Resistance Level | $12.80 | $13.05 |
| Average True Range (ATR) | 0.69 | 0.13 |
| MACD | -0.07 | 0.01 |
| Stochastic Oscillator | 6.55 | 62.50 |
Price Performance
Historical ComparisonAbout CTNM Contineum Therapeutics Inc.
Contineum Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies for NI&I indications with high unmet need. Its internally-discovered drug candidates, PIPE-791 and PIPE-307, PIPE-791, is a novel, brain penetrant, small molecule inhibitor of the LPA1R in development for IPF and PIPE-307, is a novel, small molecule selective inhibitor of the muscarinic type 1 M1R, in development for depression and RRMS.
About NMAI Nuveen Multi-Asset Income Fund of Beneficial Interest
Nuveen Multi-Asset Income Fund is a closed-end management investment company. The Fund dynamically invests in a portfolio of equity and debt securities of issuers located around the world. This dynamic investment uses a risk-based framework in which any amount can be allocated to an asset-class at any time. The Fund may invest in equity and debt securities of any type without limit.